| Mark A. Goldsmith, M.D., Ph.D. | President and Chief Executive Officer | FY2025 | |
| Steve Kelsey, M.D., FRCP, FRCPath | President, Research and Development | FY2025 | |
| Margaret Horn, J.D. | Chief Operating Officer | FY2025 | |
| Jeffrey Cislini | General Counsel and Secretary | FY2025 | |
| Jack Anders | Chief Financial Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.